Wall Street Zen Downgrades Intuitive Surgical (NASDAQ:ISRG) to Hold

Intuitive Surgical (NASDAQ:ISRG) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

ISRG has been the subject of a number of other reports. Truist Financial set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday, October 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Daiwa Capital Markets increased their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Evercore ISI boosted their target price on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn upped their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $607.17.

Intuitive Surgical Trading Up 1.2%

Shares of ISRG opened at $575.34 on Friday. The firm has a market cap of $206.25 billion, a PE ratio of 76.10, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68. The company’s 50 day simple moving average is $518.60 and its 200-day simple moving average is $505.04. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 EPS. As a group, equities research analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 22,806 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the sale, the insider owned 2,694 shares of the company’s stock, valued at $1,537,977.66. The trade was a 89.44% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 108,939 shares of company stock valued at $60,757,995. 0.70% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the company. Saranac Partners Ltd purchased a new position in shares of Intuitive Surgical in the third quarter valued at $4,325,000. Swiss Life Asset Management Ltd grew its stake in Intuitive Surgical by 7.7% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 67,483 shares of the medical equipment provider’s stock valued at $30,180,000 after acquiring an additional 4,824 shares during the last quarter. Cambria Investment Management L.P. acquired a new position in Intuitive Surgical during the third quarter worth about $318,000. KERR FINANCIAL PLANNING Corp acquired a new position in Intuitive Surgical during the third quarter worth about $33,000. Finally, Court Place Advisors LLC grew its position in shares of Intuitive Surgical by 9.7% in the third quarter. Court Place Advisors LLC now owns 5,485 shares of the medical equipment provider’s stock valued at $2,453,000 after purchasing an additional 485 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.